Drug Product

Guiding difficult to develop drug molecules from preclinical to clinical by resolving solubility, bioavailability, physical form and stability challenges

Aragen offers innovative, end-to-end solutions to accelerate clinical candidates from preclinical to clinical stages. Our scientific expertise spans formulation development, solid-state chemistry, material science, and analytics. We specialize in resolving complex challenges—including solubility, bioavailability, physical form, and stability—to enable successful drug product advancement.

Our state-of-the-art formulation and analytical labs, coupled with integrated multidisciplinary teams, ensure development of robust dosage forms while minimizing drug substance requirements. A dedicated technology transfer team ensures seamless scale-up and clinical manufacturing to support clinical trials and regulatory submissions.

Why Aragen?

Strong Scientific Expertise

• End-to-end formulation and analytical development support from discovery to CMC
• Deep expertise in pre-formulation, material science, and solid-state chemistry
• Integrated formulation and analytical characterization capabilities

Proven Technology Platforms

• Spray Dried Dispersions (SDDs/ASDs)
• Nanosuspensions
• Peptides and complex molecules
• Trusted by US/EU biotech and pharma sponsors for scientific agility and depth

Dosage Forms Developed

• Oral Solids: DiB, DiC, Immediate Release (IR), Controlled Release (CR), SDDs
• Injectables: Solutions, suspensions, nanosized formulations, long-acting injectables (LAIs)
• Topicals and other non-oral dosage forms

Dedicated Infrastructure

• 35,000 sq. ft. of purpose-built space
• Suites for preclinical, solid-state/material science, and pre-formulation
• Clinical formulation, method development, validation & stability labs
• cGMP clinical drug product manufacturing facility (solid orals for Phase I–II)

Proven Track Record

• Preclinical formulation support for 500+ NCEs
• Clinical development for 50+ drug products
• GMP clinical manufacturing and QP release for 20+ clinical batches
• Team of experienced scientists and subject matter experts (including PhDs)